NCT05136157View on ClinicalTrials.gov

Intravenous Bolus-infusion Versus Sliding Scale of Insulin for Intra-operative Glycemic Control

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

November 1, 2021

Primary Completion Date

May 25, 2022

Study Completion Date

July 15, 2022

Conditions
Intraoperative Complications
Interventions
DRUG

Rapid-Acting Insulin

50 IU of rapid acting insulin taken by a 100 units (1ml) insulin syringe will be added to a 50 ml syringe containing normal saline (NS) to have a total volume of 50 ml with a concentration of 1 IU of insulin per 1 ml of NS

Trial Locations (1)

Unknown

Ain-Shams University, Cairo

All Listed Sponsors
lead

Ain Shams University

OTHER

NCT05136157 - Intravenous Bolus-infusion Versus Sliding Scale of Insulin for Intra-operative Glycemic Control | Biotech Hunter | Biotech Hunter